Novartis investigator site

Vancouver

0 studies enrolling now · 3 studies all time

What they study most

Bipolar Disorder, COPD, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder — Completed
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed